Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
There has been a new interest in expanding the transparency of pharmaceutical markets, in many areas, including information about the outlays on R&D for the development of specific drugs. The debate over transparency legislation, still pending but stalled in California (AB 463), raised public attention to this issue worldwide and has stimulated additional interest in transparency measures in various states (notably in Colorado) and among members of Congress and in foreign countries.
Retail clinics, long seen as an antidote to more expensive doctor offices and emergency rooms, may actually boost medical spending by leading consumers to get more care, a new study shows.
ObamaCare enrollment could have a “ceiling” of around 14.7 million sign-ups, according to a new analysis from the Kaiser Family Foundation.
The Obama administration, responding to consumer complaints, says it will begin rating health insurance plans based on how many doctors and hospitals they include in their networks.
Nevada's health insurance exchange disputes a federal report claiming it misallocated funds for creating its program and recommending it consider refunding $893,000 to the Centers Medicare and Medicaid Services.
The new health maintenance organization launched by Sutter Health in 2014 more than doubled its membership in 2015, Sutter Health Plus officials say.
The biotechnology industry is pleased the Senate finally confirmed Dr. Robert Califf as commissioner of the Food and Drug Administration.
Under the Affordable Care Act, if you don't buy health insurance, you automatically face a hefty penalty, right?
Political uncertainty isn't the only threat to the Affordable Care Act's future. Cracks also are spreading through a major pillar supporting the law.
The average cost for a year's supply of a prescription drug doubled in just seven years to more than $11,000 — about three-quarters of the average annual Social Security benefit.